Supply Issues Reported in Spain Affecting Menopause Hormone Medicines
What happened
Bidafarma reported supply issues in Malaga, Spain, affecting six formulations of medicines including Evopad, Estradot, Oestraclin, and Bijuva. These medicines are used in the hormonal treatment of menopause. The issue contributes to broader drug shortages across Europe.
From surinenglish.com
Why it matters
The shortage impacts the availability of hormone replacement therapy, which is used to relieve menopause symptoms and help maintain bone mass. This contributes to the existing Europe-wide problem of drug shortages caused by high demand and production limitations.
Reports indicate Europe-wide drug shortages are occurring due to production limitations and high demand, monitored by the European Medicines Agency.
From surinenglish.com
Who's involved
- SpainLocation where the specific drug supply issues were reported
Keep exploring
Part of
Reports indicate Europe-wide drug shortages are occurring due to production limitations and high demand, monitored by the European Medicines Agency.Also in this story
- A supplier is reportedly withholding medicine from a government agency, causing market prices to rise due to supply shortages.
- The European Medicines Agency noted production limitations for the drug Creon.
The entities involved
-
Spain
country in southwestern Europe with territories in Africa